1. Home
  2. XBP vs MDXH Comparison

XBP vs MDXH Comparison

Compare XBP & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBP Europe Holdings Inc.

XBP

XBP Europe Holdings Inc.

HOLD

Current Price

$3.63

Market Cap

24.4M

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$0.42

Market Cap

21.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBP
MDXH
Founded
N/A
2003
Country
United States
Belgium
Employees
10200
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
24.4M
21.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
XBP
MDXH
Price
$3.63
$0.42
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.00
$7.67
AVG Volume (30 Days)
25.6K
524.3K
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.59
$30.78
Revenue Next Year
$5.75
$18.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.40
52 Week High
$8.55
$5.33

Technical Indicators

Market Signals
Indicator
XBP
MDXH
Relative Strength Index (RSI) 72.92 32.78
Support Level $3.31 N/A
Resistance Level $4.80 $3.79
Average True Range (ATR) 0.36 0.03
MACD 0.11 0.02
Stochastic Oscillator 89.21 7.80

Price Performance

Historical Comparison
XBP
MDXH

About XBP XBP Europe Holdings Inc.

XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: